Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Paroxysmal nocturnal hemoglobinuria–related thrombosis in the era of novel therapies: a 2043-patient-year analysis

Carmelo Gurnari, Hussein Awada, Simona Pagliuca, Danai Dima, Fauzia Ullah, Naomi Kawashima, Yasuo Kubota, Ceylan Colak, Valeria Visconte, Bhumika J. Patel, Vikram Dhillon, Naimisha Marneni, Suresh Kumar Balasubramanian, Ashwin Kishtagari, Taha Bat, Jaroslaw P. Maciejewski

Blood (2024) 144 (2): 145–155.

https://doi.org/10.1182/blood.2024023988

Published: 2024

Journal Articles

Co-Mutational Patterns with BCOR Influences Biological Characteristics and Clinical Outcomes of Myeloid Neoplasms

Jeff Aguilar, Vikram Dhillon, Sushmitha Nanja Reddy, Lakshmi Bhavani Potluri, Dakshin Padmanabhan, Jaroslaw P. Maciejewski, Julie Boerner, Gregory Dyson, Suresh Kumar Balasubramanian

Blood (2023) 142 (Supplement 1): 6445.

https://doi.org/10.1182/blood-2023-190854

Published: 2023

Journal Articles

Epigenetic Age Acceleration in Hematological Malignancies: Beyond Chronological Age, Clinical Implications, and Therapeutic Perspectives

Vikram Dhillon, Jeff Aguilar, Suresh Kumar Balasubramanian

Blood (2023) 142 (Supplement 1): 126.

https://doi.org/10.1182/blood-2023-191310

Published: 2023

Journal Articles

Concordance/Discordance of Paired Sequencing of Bone Marrow Tissue and Myeloid Sarcoma Samples- a Meta-Analysis

Dakshin Padmanabhan, Jeff Aguilar, Gregory Dyson, Lakshmi Bhavani Potluri, Vikram Dhillon, Sushmitha Nanja Reddy, Jaroslaw P. Maciejewski, Suresh Kumar Balasubramanian

Blood (2023) 142 (Supplement 1): 6013.

https://doi.org/10.1182/blood-2023-190860

Published: 2023

Journal Articles

Non-Canonical Double Mutant DNMT3A mutations: Clinical and Biological Significance in Myeloid Neoplasms

Sushmitha Nanja Reddy, Jeff Aguilar, Lakshmi Bhavani Potluri, Vikram Dhillon, Dakshin Padmanabhan, Jaroslaw P. Maciejewski, Suresh Kumar Balasubramanian, Julie Boerner, Gregory Dyson

Blood (2023) 142 (Supplement 1): 6447.

https://doi.org/10.1182/blood-2023-189972

Published: 2023

Journal Articles

Automated Peripheral Smear Recognition and Classification of LGL Leukemia Using Machine Learning

Vikram Dhillon, Jeff Aguilar, Suresh Kumar Balasubramanian

Blood (2023) 142 (Supplement 1): 3668.

https://doi.org/10.1182/blood-2023-191258

Published: 2023

Journal Articles

Co-Occurring Mutations in ASXL1 and SRSF2 Define a Unique, Prognostically Relevant Chromatin-Spliceosome Gene Signature in De Novo acute Myeloid Leukemia

Vikram Dhillon, Jeff Aguilar, Sushmitha Nanja Reddy, Lakshmi Bhavani Potluri, Jaroslaw P. Maciejewski, Suresh Kumar Balasubramanian

Blood (2023) 142 (Supplement 1): 4321.

https://doi.org/10.1182/blood-2023-191331

Published: 2023

Journal Articles

Clinical and Molecular Characteristics of NPM1 MT De Novo AML ( NPM1 MT dnAML) Differ from NPM1 MT therapy-associated AML ( NPM1 MT tAML)

Vikram Dhillon, Jeff Aguilar, Sushmitha Nanja Reddy, Lakshmi Bhavani Potluri, Gregory Dyson, Jaroslaw P. Maciejewski, Suresh Kumar Balasubramanian

Blood (2023) 142 (Supplement 1): 822.

https://doi.org/10.1182/blood-2023-191336

Published: 2023

Journal Articles

Differential Impact of Domain Stratified Non-R882 DNMT3A Mutations in Myeloid Neoplasms

Lakshmi Bhavani Potluri, Vikram Dhillon, Jeff Aguilar, Sushmitha Nanja Reddy, Dakshin Padmanabhan, Gregory Dyson, Julie Boerner, Jaroslaw P. Maciejewski, Suresh Kumar Balasubramanian

Blood (2023) 142 (Supplement 1): 1853.

https://doi.org/10.1182/blood-2023-191277

Published: 2023

Journal Articles

Real-World Outcomes of IDH Mutant AML Patients Treated with or without IDH Inhibitors

Ali Al Sbihi, Sushmitha Nanja Reddy, Vikram Dhillon, Enxhi Lalo, Harry Ramos, Abdul Moiz Khan, Suresh Kumar Balasubramanian

Blood (2022) 140 (Supplement 1): 6189–6190.

https://doi.org/10.1182/blood-2022-171131

Published: 2022

Journal Articles

Recurrent KMT2C Mutations As Clonal Hematopoiesis Is Common after Chemotherapy Exposure in Hodgkin's Lymphoma Patients

Sushmitha Nanja Reddy, Abdul Moiz Khan, Vikram Dhillon, Ali Al Sbihi, Amanda Tear, Breanna William, Sonubar Virk, Julie Boerner, Suresh Kumar Balasubramanian

Blood (2022) 140 (Supplement 1): 6584–6585.

https://doi.org/10.1182/blood-2022-170971

Published: 2022

Journal Articles

Real-World Outcomes and Cardiac Implications of FLT3 Inhibitors in Acute Myeloid Leukemia

Vikram Dhillon, Abdul Moiz Khan, Ali Al Sbihi, Sushmitha Nanja Reddy, Enxhi Lalo, Harry Ramos, Jay Yang, Anupama Kottam, Suresh Kumar Balasubramanian

Blood (2022) 140 (Supplement 1): 6183–6184.

https://doi.org/10.1182/blood-2022-169932

Published: 2022

Journal Articles

Comprehensive Age-Stratified Impact of NPM1 Mutation in Acute Myeloid Leukemia

Abdul Moiz Khan, Sushmitha Nanja Reddy, Mai M M Aly, Vikram Dhillon, Ali Al Sbihi, Tariq Kewan, Waled Bahaj, Carmelo Gurnari, Bayan Al-Share, Gregory Dyson, Valeria Visconte, Suresh Kumar Balasubramanian

Blood (2022) 140 (Supplement 1): 1433–1434.

https://doi.org/10.1182/blood-2022-165696

Published: 2022

Journal Articles

Picasso: An Open-Source Machine Learning Schema for Annotating Images in Hematology

Vikram Dhillon, Suresh Kumar Balasubramanian

Blood (2022) 140 (Supplement 1): 7854–7855.

https://doi.org/10.1182/blood-2022-171089

Published: 2022

Journal Articles

Multiple Myeloma Care in the Community Setting by Utilizing Progressive Clinical Care Pathways

Vikram Dhillon, MD, Danko Martincic, MD, Christopher M Lee, MD, Ndegwa Njuguna, MD, David Schmick, RPh, Annette K Nagle, RN, BSN, Rachel L Garman, CCRC, Hakan Kaya, MD

Blood (2012) 120 (21): 5053.

https://doi.org/10.1182/blood.V120.21.5053.5053

Published: 2012

NARROW

Paroxysmal nocturnal hemoglobinuria–related thrombosis in the era of novel therapies: a 2043-patient-year analysis

Co-Mutational Patterns with BCOR Influences Biological Characteristics and Clinical Outcomes of Myeloid Neoplasms

Epigenetic Age Acceleration in Hematological Malignancies: Beyond Chronological Age, Clinical Implications, and Therapeutic Perspectives

Concordance/Discordance of Paired Sequencing of Bone Marrow Tissue and Myeloid Sarcoma Samples- a Meta-Analysis

Non-Canonical Double Mutant DNMT3A mutations: Clinical and Biological Significance in Myeloid Neoplasms

Automated Peripheral Smear Recognition and Classification of LGL Leukemia Using Machine Learning

Co-Occurring Mutations in ASXL1 and SRSF2 Define a Unique, Prognostically Relevant Chromatin-Spliceosome Gene Signature in De Novo acute Myeloid Leukemia

Clinical and Molecular Characteristics of NPM1 MT De Novo AML ( NPM1 MT dnAML) Differ from NPM1 MT therapy-associated AML ( NPM1 MT tAML)

Differential Impact of Domain Stratified Non-R882 DNMT3A Mutations in Myeloid Neoplasms

Real-World Outcomes of IDH Mutant AML Patients Treated with or without IDH Inhibitors

Recurrent KMT2C Mutations As Clonal Hematopoiesis Is Common after Chemotherapy Exposure in Hodgkin's Lymphoma Patients

Real-World Outcomes and Cardiac Implications of FLT3 Inhibitors in Acute Myeloid Leukemia

Comprehensive Age-Stratified Impact of NPM1 Mutation in Acute Myeloid Leukemia

Picasso: An Open-Source Machine Learning Schema for Annotating Images in Hematology

Multiple Myeloma Care in the Community Setting by Utilizing Progressive Clinical Care Pathways

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only